Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
Clinical trial NCT03515798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03515798
- Sponsor
- Institut Paoli-Calmettes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2022-08-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.